183 related articles for article (PubMed ID: 21246557)
1. Monitoring of antisolvent crystallization of sodium scutellarein by combined FBRM-PVM-NIR.
Liu X; Sun D; Wang F; Wu Y; Chen Y; Wang L
J Pharm Sci; 2011 Jun; 100(6):2452-9. PubMed ID: 21246557
[TBL] [Abstract][Full Text] [Related]
2. In-line monitoring and interpretation of an indomethacin anti-solvent crystallization process by near-infrared spectroscopy (NIRS).
Lee HE; Lee MJ; Kim WS; Jeong MY; Cho YS; Choi GJ
Int J Pharm; 2011 Nov; 420(2):274-81. PubMed ID: 21907779
[TBL] [Abstract][Full Text] [Related]
3. Monitoring granulation rate processes using three PAT tools in a pilot-scale fluidized bed.
Tok AT; Goh X; Ng WK; Tan RB
AAPS PharmSciTech; 2008; 9(4):1083-91. PubMed ID: 18850276
[TBL] [Abstract][Full Text] [Related]
4. Developing an environmentally benign process for the production of microparticles: amphiphilic crystallization.
Murnane D; Marriott C; Martin GP
Eur J Pharm Biopharm; 2008 May; 69(1):72-82. PubMed ID: 18082385
[TBL] [Abstract][Full Text] [Related]
5. Enhancing crystalline properties of a cardiovascular active pharmaceutical ingredient using a process analytical technology based crystallization feedback control strategy.
Saleemi AN; Steele G; Pedge NI; Freeman A; Nagy ZK
Int J Pharm; 2012 Jul; 430(1-2):56-64. PubMed ID: 22449455
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of apigenin nanoparticles using antisolvent crystallization technology: A comparison of supercritical antisolvent, ultrasonic-assisted liquid antisolvent, and high-pressure homogenization technologies.
Yan T; Wang H; Song X; Yan T; Ding Y; Luo K; Zhen J; He G; Nian L; Wang S; Wang Z
Int J Pharm; 2022 Aug; 624():121981. PubMed ID: 35792228
[TBL] [Abstract][Full Text] [Related]
7. A PAT approach for the on-line monitoring of pharmaceutical co-crystals formation with near infrared spectroscopy.
Sarraguça MC; Ribeiro PR; Santos AO; Silva MC; Lopes JA
Int J Pharm; 2014 Aug; 471(1-2):478-84. PubMed ID: 24907598
[TBL] [Abstract][Full Text] [Related]
8. Crystallization of progesterone for pulmonary drug delivery.
Ragab D; Rohani S; Samaha MW; El-Khawas FM; El-Maradny HA
J Pharm Sci; 2010 Mar; 99(3):1123-37. PubMed ID: 19691108
[TBL] [Abstract][Full Text] [Related]
9. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
[TBL] [Abstract][Full Text] [Related]
10. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
[TBL] [Abstract][Full Text] [Related]
11. Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization.
Murnane D; Marriott C; Martin GP
Eur J Pharm Biopharm; 2008 May; 69(1):94-105. PubMed ID: 17981448
[TBL] [Abstract][Full Text] [Related]
12. A Process Analytical Technology (PAT) approach to control a new API manufacturing process: development, validation and implementation.
Schaefer C; Clicq D; Lecomte C; Merschaert A; Norrant E; Fotiadu F
Talanta; 2014 Mar; 120():114-25. PubMed ID: 24468350
[TBL] [Abstract][Full Text] [Related]
13. Applications of NIR spectroscopy to monitoring and analyzing the solid state during industrial crystallization processes.
Févotte G; Calas J; Puel F; Hoff C
Int J Pharm; 2004 Apr; 273(1-2):159-69. PubMed ID: 15010140
[TBL] [Abstract][Full Text] [Related]
14. Applications of process analytical technology to crystallization processes.
Yu LX; Lionberger RA; Raw AS; D'Costa R; Wu H; Hussain AS
Adv Drug Deliv Rev; 2004 Feb; 56(3):349-69. PubMed ID: 14962586
[TBL] [Abstract][Full Text] [Related]
15. Process intensification of atorvastatin calcium crystallization for target polymorph development via continuous combined cooling and antisolvent crystallization using an oscillatory baffled crystallizer.
Kshirsagar S; Lakshmi Ramana Susarla N; Ramakrishnan S; Nagy ZK
Int J Pharm; 2022 Nov; 627():122172. PubMed ID: 36084877
[TBL] [Abstract][Full Text] [Related]
16. Application of direct crystallization for racemic compound propranolol hydrochloride.
Wang X; Lu J; Ching CB
J Pharm Sci; 2007 Oct; 96(10):2735-45. PubMed ID: 17549769
[TBL] [Abstract][Full Text] [Related]
17. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
18. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
[TBL] [Abstract][Full Text] [Related]
19. Agglomerative crystallization of ABT-510 in a partially miscible solvent system.
Sheikh AY; Pal A; Viswanath S; Tolle JC
J Pharm Sci; 2008 Mar; 97(3):1202-12. PubMed ID: 17683060
[TBL] [Abstract][Full Text] [Related]
20. Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives.
Kumar R; Thakur AK; Banerjee N; Kumar A; Gaurav GK; Arya RK
Drug Deliv Transl Res; 2023 Feb; 13(2):400-418. PubMed ID: 35953765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
